ALKYLAMINE
Alkyl Amines Chemicals Limited (ALKYLAMINE) pushes higher, gains 6% intraday
Alkyl Amines Chemicals Limited (NSE: ALKYLAMINE) stock is up 6% intraday to ₹1938.0, extending gains but not clearing resistance.
Alkyl Amines Chemicals Limited (ALKYLAMINE) extended gains by +6% to ₹1938.0 on the NSE today, recovering from a breakdown and now consolidating upwards. This move follows the company’s recent announcement regarding a change in directorship and the submission of financial results for the period ended Jun 30, 2026. In the specialty chemicals sector, ALKYLAMINE’s performance today indicates a company-specific recovery rather than broad sector momentum.
Technical setup — trendlines & DMA
From a technical standpoint, ALKYLAMINE is currently trading above its 6-month support trendline, which ends at ₹1825.3, representing a 5.82% buffer. Resistance is set at ₹2021.1, with the stock currently 4.29% below this level. The 50-day moving average (DMA) at ₹1802.2 is above the 200-DMA at ₹1624.8, signaling a bullish trend. The stock is positioned in the middle third of its 52-week range, suggesting that while there is room for further upside, a significant portion of the potential move may already be priced in.
Snapshot: ₹1,938.00 on 2026-08-04 (chart frozen at publication)
Fundamentals & business context
Fundamentally, ALKYLAMINE presents a mixed picture. With a PE ratio of 51.9 and profit margins at 11.8%, the valuation appears stretched given the revenue CAGR of -3.0% over the past five years. This suggests that the market may be pricing in expectations of a turnaround that the current business performance does not yet support. Institutional ownership stands at 5.2%, indicating a cautious approach by smart money. There was no specific NSE catalyst today beyond the routine corporate announcements.
Algorithmic scorecard
The algorithmic scorecard reflects a technically strong but fundamentally weak profile for ALKYLAMINE. The strongest signals include bullish sentiment over the last 30 days, with a 2.47x higher average volume on up days compared to down days, indicating systematic accumulation. Additionally, the stock’s very low debt level, with a D/E ratio of 0.00, underscores excellent financial health. On the weaker side, the declining revenue and profit CAGRs over five years highlight growth challenges, and the negligible dividend yield of 0.76% offers little income to investors. These factors present a risk-reward balance that investors must carefully consider.
Company outlook
Management’s outlook for ALKYLAMINE indicates expected volume growth of 5% to 10% in the next year, with margins anticipated to improve but not returning to pre-February levels soon. There are no major new capex plans for existing products, but the company has outlined planned capex of INR 80 crores to INR 90 crores for FY27 and FY28. This forward-looking guidance suggests a cautious yet optimistic approach to growth, with a focus on strategic investments rather than broad-based expansion.
Get all details on ALKYLAMINE — P&L, peers, shareholding and more on TradeAlone.
ALKYLAMINE
Alkyl Amines Chemicals Limited (ALKYLAMINE) breaks out, moves up 5% intraday
Alkyl Amines Chemicals Limited (NSE: ALKYLAMINE) stock price moves up 5% intraday to ₹1947.3, clearing its 6M resistance trendline in a breakout move.
Alkyl Amines Chemicals Limited (ALKYLAMINE) breaks out with a +5% gain to clear its 6-month resistance trendline at ₹1908, driven by strong technical momentum. This move comes despite a backdrop of declining revenue and profit growth over the past five years, highlighting a divergence between technical setup and fundamental performance. The stock’s breakout aligns with improving sentiment in the specialty chemicals sector, though today’s move appears more company-specific given the lack of broader sector catalysts.
Technical setup — trendlines & DMA
From a chart perspective, ALKYLAMINE has established a solid support floor at ₹1786.47, which is 8.26% below today’s price, indicating a strong base. The recent breakout above the 6-month resistance at ₹1907.8 suggests a potential shift in trend. The 50-day moving average (DMA) at ₹1736.0 is above the 200-DMA at ₹1628.2, signaling a bullish trend. The stock is currently trading 6.77% above the 50-DMA and 13.84% above the 200-DMA, suggesting it is in an uptrend but not overextended. Within its 52-week range of ₹1212.0 to ₹2426.2, the stock is in the middle third, implying there is room for further upside if the breakout sustains.
Snapshot: ₹1,947.30 on 2026-07-09 (chart frozen at publication)
Fundamentals & business context
Despite the technical breakout, ALKYLAMINE’s fundamental picture presents challenges. With a PE of 52.7 against an 11.8% profit margin and a 5-year revenue CAGR of -3.0%, the valuation appears stretched relative to current earnings. The declining profit CAGR of -7.7% over five years raises questions about the sustainability of the current price levels. Institutional ownership stands at a modest 5.2%, indicating a cautious approach by larger investors. There were no specific NSE catalysts today, suggesting the move is driven by technical factors rather than new fundamental developments.
Algorithmic scorecard
The algorithmic scorecard reflects a stock that is technically robust but fundamentally weak. The overall score of 59 highlights this dichotomy. On the positive side, the stock exhibits bullish sentiment with a ratio of 4.95x higher volume on up days compared to down days over the last 30 days, indicating systematic accumulation. Additionally, the low volatility with a beta of 0.30 suggests it is a stable stock with less market risk. However, the declining revenue and profit CAGR over five years, coupled with a negligible dividend yield of 0.76%, presents significant risks. These factors could limit upside potential and expose the stock to downside if technical momentum wanes.
Company outlook
Management provided forward guidance indicating an expected volume growth of 5% to 10% in the next year, though margins are not expected to return to pre-February levels soon. There are no major new capex plans for existing products, but the company has outlined planned capex of INR 80 crores to INR 90 crores for FY27 and FY28. This investment suggests a focus on strategic growth areas, though the specific segments or products driving this growth were not detailed in the provided outlook.
Get all details on ALKYLAMINE — P&L, peers, shareholding and more on TradeAlone.
ALKYLAMINE
Alkyl Amines Chemicals Limited (ALKYLAMINE) gains 6% intraday, tests resistance
Alkyl Amines Chemicals Limited (NSE: ALKYLAMINE) moves up 6% intraday to ₹1904.9, nearing resistance at ₹1902 in the Specialty Chemicals sector.
Alkyl Amines Chemicals Limited (ALKYLAMINE) gained +6% to test resistance at ₹1904.9 on the NSE on 08 Jul 2026. The move comes as the stock approaches a key resistance level at ₹1902, just 0.2% away. This is a specialty chemicals company within the basic materials sector, and today’s move appears to be driven by technical factors rather than sector momentum or specific company news.
Technical setup — trendlines & DMA
From a technical perspective, the stock has recently broken above its 6M resistance trendline at ₹1901.95, indicating a potential shift in momentum. The 6M support trendline is at ₹1491.56, which is 21.70% below the current price, providing a solid floor. The 50-DMA at ₹1730.9 is above the 200-DMA at ₹1628.9, suggesting a bullish trend. However, the stock is currently trading in the middle third of its 52-week range, indicating that much of the potential upside may already be priced in.
Snapshot: ₹1,904.90 on 2026-07-08 (chart frozen at publication)
Fundamentals & business context
On the fundamental side, the stock’s PE of 51.2 appears stretched given the current profit margin of 11.8% and a declining revenue CAGR of -3.0%. This suggests that the market may be pricing in a turnaround that the current business performance does not yet justify. Institutional ownership stands at 5.2%, indicating a cautious approach from smart money. There were no specific NSE catalysts today that would explain the move, reinforcing the technical nature of today’s gain.
Algorithmic scorecard
The algorithmic scorecard reflects a technically strong but fundamentally weak stock. The overall score of 59 indicates a balanced but cautious view. The strongest signals are the bullish trend, with the 50-DMA above the 200-DMA, and the bullish sentiment over the last 30 days, where up days have seen significantly higher volumes than down days. However, the weakest signals are the declining revenue and profit CAGRs, which highlight the challenges the company faces in growing its top and bottom lines. Additionally, the negligible dividend yield of 0.76% offers little income for investors, making the stock more reliant on capital appreciation.
Company outlook
Management provided an outlook for expected volume growth of 5% to 10% in the next year, although margins are not expected to return to pre-February levels soon. There are no major new capex plans for existing products, but the company does plan to invest INR 80 crores to INR 90 crores in FY27 and FY28. This outlook suggests a cautious but positive trajectory for the company, with growth expected to come from incremental volume increases rather than margin expansion.
Get all details on ALKYLAMINE — P&L, peers, shareholding and more on TradeAlone.
ALKYLAMINE
Alkyl Amines Chemicals Limited (ALKYLAMINE) eases after clearing resistance, down 5% intraday
Alkyl Amines Chemicals Limited (NSE: ALKYLAMINE) shows pressure after breakout, down 5% intraday at ₹1692.0.
Alkyl Amines Chemicals Limited (ALKYLAMINE) fell -5% today, approaching a key support level after breaking below its 6-month support trendline. This move is technical, driven by the stock’s recent performance relative to its trendlines and moving averages. ALKYLAMINE operates in the specialty chemicals segment within the basic materials sector, and today’s decline appears to be company-specific rather than a sector-wide movement.
Technical setup — trendlines & DMA
Currently, the 6-month support trendline for ALKYLAMINE stands at ₹1501.04, which is approximately 11.29% below today’s price. The resistance trendline is at ₹1885.71, about 11.45% above the current price. The 50-day moving average (DMA) is ₹1689.8, slightly below today’s price, while the 200-DMA is ₹1637.9, indicating a bullish trend as the 50-DMA is above the 200-DMA. ALKYLAMINE is currently trading in the middle third of its 52-week range, suggesting that a significant portion of the potential downside may already be priced in.
Snapshot: ₹1,692.00 on 2026-06-29 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 50.9 and profit margins at 11.8%, ALKYLAMINE’s valuation appears stretched given its revenue CAGR of -3.0% over the past five years. This suggests that the market may be pricing in a potential turnaround that the current business performance does not yet justify. Institutional ownership stands at 5.2%, indicating a cautious approach by smart money, likely due to the company’s declining revenue and profit growth. There is no NSE catalyst today, making the move purely technical.
Algorithmic scorecard
The overall algorithmic scorecard reflects a stock that is technically strong but fundamentally weak. The strongest signals include the bullish sentiment over the last 30 days, with a significant volume disparity between up and down days, indicating systematic accumulation. Additionally, the stock’s low volatility, with a beta of 0.30, suggests it is a stable investment with less market risk. On the weaker side, the declining revenue and profit CAGRs over five years highlight structural challenges, and the negligible dividend yield of 0.76% offers little income to investors, making the stock less attractive from an income perspective.
Company outlook
Management provided forward guidance indicating an expected volume growth of 5% to 10% in the next year, with margins anticipated to improve but not return to pre-February levels soon. No major new capex is planned for existing products, but there is a planned capex of INR 80 crores to INR 90 crores for FY27 and FY28. This outlook suggests a focus on controlled expansion and efficiency improvements rather than aggressive growth initiatives.
Get all details on ALKYLAMINE — P&L, peers, shareholding and more on TradeAlone.
-
Auto Manufacturers2 days agoEicher Motors Limited (eichermot): Born Airborne, Flying Flea C6 Launches in Europe
-
Auto Parts2 days agoSona BLW Precision Forgings Limited Sonacoms: Strategic Shift at Jefferies India Forum 5th Edition
-
Healthcare2 days agoYatharth Hospital & Trauma Care Services Limited (yatharth) Secures Rs 3,150 Crore Investment from Advent International for 24.9% Stake
-
Auto Manufacturers2 days agoTvs Motor Company Limited (tvsmotor) Announces Festive Season Enhancements to Premium Motorcycle Portfolio
-
PURVA2 days agoPuravankara Limited Secures ₹2,600 Crore Redevelopment Project in Goregaon West, Mumbai
-
SOFTTECH2 days agoSofttech Engineers Limited Secures Rs. 92.95 Crores Project from JNPA for Ai-enabled Digital Twin
-
Communication Services2 days agoImagicaaworld Entertainment Limited Announces ₹248 Crore Hotel Transaction, Unlocking Significant Value
-
Information Technology Services2 days agoWipro Limited (wipro) Collaborates with Aramco and SAP to Launch Wipro Sto360™